Although there were numerical improvements in PFS and overall survival, the combination therapy did not reach statistical significance in enhancing overall survival and PFS compared to placebo.
← all excerpts
Current perspectives on the pharmacological treatment of advanced hepatocellular carcinoma: a narrative review.
1
—
—